跳至主要内容
临床试验/NCT03225729
NCT03225729已完成不适用

Prospective Clinical Trial to Assess the Performance of a Cyto-selective Cryotherapye "CRYOBEAUTY MAINS ET DECOLLETE" Compared With Liquid Nitrogen Cryotherapy in the Treatment of Solar Lentigines in 30 Patients

Cryobeauty1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2017年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cryobeauty
入组人数
30
试验地点
1
主要终点
Performance assessment of new cryotherapy device "CRYOTHERAPY MAIN ET DECOLLETE" to treat solar lentigo spots on the hands.

研究概览

简要总结

This study evaluates the performance of new technology "CRYOTHERAPY MAINS ET DECOLLETE" against a classic cryotherapy "Nitrogen Liquid " to treat solar lentigines.

The hands and the neckline will be randomised, either left or right side and treated by two cryotherapy devices:

  1. CRYOTHERAPY MAINS ET DECOLLETE is the device under evaluation.
  2. Liquid nitrogen is a comparator device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Phototype II to IV
  • Presenting solar lentigos on both hands and neck, diameter ≤ 6mm
  • Accepting not to expose the body to sunlight or artificial UV rays during the study
  • Affiliate to a health insurance plan
  • Having undergone a general clinical examination attesting to his / her ability to participate in the study
  • Having given written consent

排除标准

  • Having carried out aesthetic care (exfoliants, scrubs or self-tanning, manicure, hand care, UV ...) in the month before the start of the study, at the level of the hands and/or neckline.
  • Having applied a depigmenting product in the month preceding the start of the study, at the level of the hands and/or neckline.
  • Having carried out aesthetic care at a dermatologist (laser, IPL, peeling, depigmenting creams, cryotherapy ...), at the level of the hands and/or neckline, during the last six months
  • Dermatosis, autoimmune disease (vitiligo), systemic, chronic or acute disease, or any other disease that may interfere with the treatment or influence the results of the study (people with diabetes, circulatory problems, cold allergies, With Raynaud's syndrome ...)
  • Receiving general or local treatment (corticosteroids ...) likely to interfere with the evaluation of the studied parameters.
  • Participating in another study or being in an exclusion period from a previous study
  • Being incapable of following the requirements of the protocol
  • Person protected by law
  • Unable to read and write French
  • Pregnant woman or woman wishing to be pregnant during the study, or during breastfeeding period
  • Women of childbearing age who do not have contraception

结局指标

主要结局

Performance assessment of new cryotherapy device "CRYOTHERAPY MAIN ET DECOLLETE" to treat solar lentigo spots on the hands.

时间窗: 8 weeks

Evaluation of CRYOBEAUTY MAINS's performance Hexsel scoring: 1. \> Very significant clearance (about 90%); only minor evidence of hyper pigmentation remains 2. \> Significant improvement (about 75%); some signs of hyper pigmentation remains 3. \> Intermediate between marked and slight improvement; about 50% improvement in the appearance of hyper pigmentation 4. \> Some improvement (about 25%); however, significant evidence of hyper pigmentation remains 5. \> Hyperpigmentation has not changed since baseline 6. \> Worse (hyperpigmentation is worse than at baseline)

次要结局

  • Incidence of Treatment-Emergent Adverse Events(8 weeks)
  • Assessment of ergonomic and device's readiness(0 weeks)
  • Assessment of volunteers feeling (QoL)(0 weeks)
  • Pain assessment(0 weeks)
  • Evolution of spot's colour(8 weeks)
  • Performance assessment of CRYOBEAUTY HANDS AND DECOLLETE on the spots of the neckline.(8 weeks)

研究者

发起方
Cryobeauty
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验